27.3 C
New York

Understanding Metastatic Malignant Mesothelioma | Symptoms, Treatment, and Prognosis



Malignant mesothelioma is a rare and aggressive cancer that affects the mesothelium, a thin layer of tissue that covers the internal organs. It is most commonly known to be caused by exposure to asbestos, but there are other risk factors as well. One of the most distressing aspects of this disease is its ability to spread, or metastasize, to other parts of the body. This often happens before any noticeable symptoms appear, making it difficult to detect and treat early on.

In this article, we will delve into the complexities of metastatic malignant mesothelioma and explore its symptoms, diagnosis, treatment options, and prognosis. It is a silent killer that requires greater understanding and awareness in order to improve survival rates and provide better care for those affected by this disease.

What is Metastatic Malignant Mesothelioma?

Understanding Metastatic Malignant Mesothelioma | Symptoms, Treatment, and Prognosis

Mesothelioma is a type of cancer that starts in the mesothelial cells, which are found in the lining of certain organs such as the lungs, heart, and abdomen. When this cancer spreads from its original site to other parts of the body, it is called metastatic malignant mesothelioma.

The three main types of mesothelioma are pleural mesothelioma, peritoneal mesothelioma, and pericardial mesothelioma. Pleural mesothelioma affects the lining of the lungs, while peritoneal mesothelioma affects the lining of the abdomen. Pericardial mesothelioma, which is the rarest form, affects the lining of the heart.

Metastatic malignant mesothelioma is an advanced stage of the disease, with cancer cells spreading beyond the initial location to distant sites such as the bones, liver, or brain. This makes it more difficult to treat and significantly impacts the chances of survival.

Risk Factors for Metastatic Malignant Mesothelioma

The primary risk factor for mesothelioma is exposure to asbestos, a naturally occurring mineral that was widely used in various industries until the 1980s. When asbestos fibers are inhaled, they can get stuck in the lining of the lungs, causing damage and inflammation over time. Overexposure to asbestos can eventually lead to the development of mesothelioma.

Other risk factors for mesothelioma include:

  • Occupational exposure: Workers in industries such as mining, construction, and shipbuilding are at a higher risk due to their direct contact with asbestos.
  • Environmental exposure: Asbestos can also be found in the environment, particularly in areas with natural deposits of the mineral.
  • Genetic predisposition: Certain genetic mutations may increase the risk of developing mesothelioma, although this is still being studied.

Symptoms of Metastatic Malignant Mesothelioma

Understanding Metastatic Malignant Mesothelioma | Symptoms, Treatment, and Prognosis

One of the most challenging aspects of mesothelioma is its elusive symptoms, which can often be attributed to other conditions. In its early stages, metastatic malignant mesothelioma may present with mild or vague symptoms, making it difficult to diagnose and treat.

Some common symptoms of metastatic malignant mesothelioma include:

  • Shortness of breath
  • Chest pain
  • Fatigue
  • Coughing
  • Weight loss
  • Abdominal pain or swelling
  • Nausea or vomiting

These symptoms can vary depending on the location of the cancer cells and the stage of the disease. For example, if the cancer has spread to the abdomen, a person may experience abdominal pain or swelling, while those with pericardial mesothelioma may experience heart palpitations or chest pain.

The Role of Tumor Markers in Diagnosis

In addition to a physical exam and imaging tests, doctors may also use tumor markers to help diagnose mesothelioma. Tumor markers are substances that are found in the blood, urine or tissue of patients with certain types of cancer. For mesothelioma, two specific markers have been identified – mesothelin and osteopontin.

However, these markers are not specific to mesothelioma and can also be present in other conditions such as lung cancer and pleural plaques. Therefore, they are not used as a sole method for diagnosis but rather in conjunction with other tests.

Diagnosis and Staging

Diagnosing metastatic malignant mesothelioma can be challenging due to its non-specific symptoms and the rarity of the disease. It often involves a series of tests and procedures to confirm the presence of mesothelioma and determine its stage.

Imaging Tests

Imaging tests such as X-rays, CT scans, and MRIs can help identify any abnormalities in the body and locate the site of the primary tumor. These tests are also useful in determining the size and spread of the cancer.


A biopsy is the only way to definitively diagnose mesothelioma. It involves removing a small sample of tissue from the affected area and examining it under a microscope. The type of biopsy performed depends on the location of the suspected tumor, with options including needle biopsies, thoracoscopy, laparoscopy, or mediastinoscopy.


Staging is the process of determining how far the cancer has spread. In the case of metastatic malignant mesothelioma, the cancer has already spread to distant sites, making it a stage 4 cancer. However, further staging may still be necessary to guide treatment decisions and assess the prognosis.

The most commonly used staging system for mesothelioma is the TNM system, which stands for Tumor, Nodes, and Metastases. It takes into account the size of the primary tumor, its location, lymph node involvement, and presence of distant metastasis.

Treatment Options

Treatment for metastatic malignant mesothelioma is often palliative, meaning it focuses on controlling symptoms and improving overall quality of life rather than aiming for a cure. The treatment approach varies depending on the type of mesothelioma, stage of the disease, and the overall health of the patient.


Surgery may be recommended to remove the primary tumor and any visible metastases. This is typically only an option for patients with earlier stages of the disease and good overall health. The type of surgery performed depends on the location of the cancer, with options including:

  • Pleurectomy/decortication (P/D): The removal of part of the pleura, the lining of the lungs.
  • Extrapleural pneumonectomy (EPP): The removal of the entire lung, the pleura, part of the diaphragm, and the pericardium.

Surgery can help improve symptoms and potentially prolong survival, but it is not considered a curative treatment for metastatic malignant mesothelioma.


Chemotherapy involves using drugs to kill cancer cells or stop them from growing. It is often used in combination with surgery or radiation therapy to shrink tumors and prevent them from spreading further.

The most common chemotherapy regimen for mesothelioma is a combination of cisplatin and pemetrexed. While this treatment can help slow down the progression of the disease, it also comes with significant side effects such as nausea, hair loss, and fatigue.

Radiation Therapy

Radiation therapy uses high-energy beams to target and destroy cancer cells. It may be used before or after surgery to shrink tumors or relieve symptoms such as pain or difficulty breathing.

One of the challenges of using radiation therapy for metastatic malignant mesothelioma is limiting the damage to surrounding healthy tissue. However, advancements in technology have helped make the treatment more precise and effective.

Prognosis and Survival Rates

The prognosis for metastatic malignant mesothelioma is often poor, with the average survival rate being less than one year. This is due to the disease being diagnosed at an advanced stage, making it more challenging to treat.

However, individual factors such as age, overall health, and response to treatment can also impact survival rates. For example, patients who are younger and in good overall health may have a better chance of responding well to treatment and living longer.

Other factors that can influence survival rates include:

  • Type of mesothelioma: Peritoneal mesothelioma has a better prognosis compared to pleural or pericardial mesothelioma.
  • Stage of the disease: The earlier the cancer is detected and treated, the better the chances of survival.
  • Treatment response: Patients who respond well to treatment and experience fewer side effects may have a better prognosis.

Clinical Trials

As mesothelioma remains a rare and understudied disease, clinical trials play a crucial role in advancing treatment options. These trials involve testing new treatments or combinations of treatments on willing participants to determine their effectiveness and safety.

Participating in a clinical trial can provide access to cutting-edge treatments that may not be available otherwise. It is important to discuss with your doctor if a clinical trial is a suitable option for you.


Metastatic malignant mesothelioma is a silent killer that requires greater awareness and understanding to improve diagnosis and treatment outcomes. Its complex nature, limited treatment options, and difficult diagnosis make it a challenging disease to manage.

However, advancements in research and technology offer hope for improved treatments and better survival rates. By increasing awareness and promoting preventive measures, we can work towards reducing the number of people affected by this deadly disease.

Related articles

Recent articles